A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Inactivation of the tumor suppressor gene, CDKN2A, can occur by deletion, methylation, or mutation. We assessed the principal mode of inactivation in childhood acute lymphoblastic leukemia (ALL) and frequency in biologically relevant subgroups. Mutation or methylation was rare, whereas genomic deletion occurred in 21% of B-cell precursor ALL and 50% of T-ALL patients. Single nucleotide polymorphism arrays revealed copy number neutral (CNN) loss of heterozygosity (LOH) in 8% of patients. Array-based comparative genomic hybridization demonstrated that the mean size of deletions was 14.8 Mb and biallelic deletions composed a large and small deletion (mean sizes, 23.3 Mb and 1.4 Mb). Among 86 patients, only 2 small deletions were below the resolution of detection by fluorescence in situ hybridization. Patients with high hyperdiploidy, ETV6-RUNX1, or 11q23/MLL rearrangements had low rates of deletion (11%, 15%, 13%), whereas patients with t(9;22), t(1;19), TLX3, or TLX1 rearrangements had higher frequencies (61%, 42%, 78%, and 89%). In conclusion, CDKN2A deletion is a significant secondary abnormality in childhood ALL strongly correlated with phenotype and genotype. The variation in the incidence of CDKN2A deletions by cytogenetic subgroup may explain its inconsistent association with outcome. CNN LOH without apparent CDKN2A inactivation suggests the presence of other relevant genes in this region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Research works printed but not linked: 55
- Sandal, 2002, Molecular aspects of the mammalian cell cycle and cancer., Oncologist, 7, 73, 10.1634/theoncologist.7-1-73 · DOI
- Drexler, 1998, Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells., Leukemia, 12, 845, 10.1038/sj.leu.2401043 · DOI · Paper page
- Krug, 2002, Tumor suppressor genes in normal and malignant hematopoiesis., Oncogene, 21, 3475, 10.1038/sj.onc.1205322 · DOI · Paper page
- Baccichet, 1997, Allelic loss in childhood acute lymphoblastic leukemia., Leukemia Res, 21, 817, 10.1016/S0145-2126(97)00075-1 · DOI
- Takeuchi, 1997, Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis., Leukemia, 11, 1636, 10.1038/sj.leu.2400817 · doi:10.1038/sj.leu.2400817
- Takeuchi, 2003, Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia., Leukemia, 17, 149, 10.1038/sj.leu.2402727 · doi:10.1038/sj.leu.2402727
- Irving, 2005, Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis., Cancer Res, 65, 3053, 10.1158/0008-5472.CAN-04-2604 · DOI
- Komuro, 1999, p27KIP1 deletions in childhood acute lymphoblastic leukemia., Neoplasia, 1, 253, 10.1038/sj.neo.7900033 · DOI
- Kwabi-Addo, 2001, Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression., Proc Natl Acad Sci U S A, 98, 11563, 10.1073/pnas.201167798 · DOI · Paper page
- Chapman, 2005, Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype., Clin Cancer Res, 11, 5740, 10.1158/1078-0432.CCR-05-0411 · DOI
- Ohnishi, 1995, Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia., Blood, 86, 1269, 10.1182/blood.V86.4.1269.bloodjournal8641269 · DOI · Paper page
- Bertin, 2003, CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia., Genes Chromosomes Cancer, 37, 44, 10.1002/gcc.10188 · DOI
- Iravani, 1997, Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia., Oncogene, 15, 2609, 10.1038/sj.onc.1201428 · doi:10.1038/sj.onc.1201428
- Wong, 2000, Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications., Blood, 95, 1942, 10.1182/blood.V95.6.1942 · DOI · Paper page
- Gutierrez, 2003, Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup., Leukemia, 17, 1845, 10.1038/sj.leu.2403060 · DOI
- Chim, 2003, Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias., Ann Hematol, 82, 738, 10.1007/s00277-003-0744-8 · DOI
- Roman-Gomez, 2004, Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia., Blood, 104, 2492, 10.1182/blood-2004-03-0954 · DOI · Paper page
- Matsushita, 2004, Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia., Oncol Rep, 12, 97
- Lemos, 2003, Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias., Sao Paulo Med J, 121, 58, 10.1590/S1516-31802003000200005 · doi:10.1590/s1516-31802003000200005
- Kawamura, 1999, Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia., Leukemia Res, 23, 115, 10.1016/S0145-2126(98)00146-5 · DOI
- Takeuchi, 1995, Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood., Blood, 86, 755, 10.1182/blood.V86.2.755.bloodjournal862755 · DOI
- Rasool, 1995, p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia., Blood, 85, 3431, 10.1182/blood.V85.12.3431.bloodjournal85123431 · DOI · Paper page
- Quesnel, 1995, p16 gene homozygous deletions in acute lymphoblastic leukemia., Blood, 85, 657, 10.1182/blood.V85.3.657.bloodjournal853657 · DOI · Paper page
- Harrison, 2001, The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: a valuable resource for patient management., Br J Haematol, 113, 3, 10.1046/j.1365-2141.2001.02643.x · doi:10.1046/j.1365-2141.2001.02643.x
- Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands., Proc Natl Acad Sci U S A, 93, 9821, 10.1073/pnas.93.18.9821 · DOI · Paper page
- Nannya, 2005, A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays., Cancer Res, 65, 6071, 10.1158/0008-5472.CAN-05-0465 · DOI · Paper page
- Strefford, 2006, Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21., Proc Natl Acad Sci U S A, 103, 8167, 10.1073/pnas.0602360103 · DOI
- Barrett, 2004, Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA., Proc Natl Acad Sci U S A, 101, 17765, 10.1073/pnas.0407979101 · DOI · Paper page
- Strefford, 2007, Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization., Oncogene, 26, 4306, 10.1038/sj.onc.1210190 · DOI
- Jalali, 2007, Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia., Leukemia, 22, 114, 10.1038/sj.leu.2404994 · DOI
- Akasaka, 2007, Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)., Blood, 109, 3451, 10.1182/blood-2006-08-041012 · DOI · Paper page
- Metaxa-Mariatou, 2004, Molecular analysis of GISTs: evaluation of sequencing and dHPLC., DNA Cell Biol, 23, 777, 10.1089/dna.2004.23.777 · doi:10.1089/dna.2004.23.777
- Yarbrough, 1999, Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors., J Natl Cancer Inst, 91, 1569, 10.1093/jnci/91.18.1569 · DOI
- Sakano, 2003, Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene., Int J Cancer, 104, 98, 10.1002/ijc.10919 · DOI
- Schneider-Stock, 2003, High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors., J Clin Oncol, 21, 1688, 10.1200/JCO.2003.08.101 · DOI
- Deligezer, 2006, Methylation of the INK4A/ARF locus in blood mononuclear cells., Ann Hematol, 85, 102, 10.1007/s00277-005-0041-9 · DOI
- Mullighan, 2007, Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia., Nature, 446, 758, 10.1038/nature05690 · DOI · Paper page
- Usvasalo, 2008, CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study., Leukemia Res, 32, 1228, 10.1016/j.leukres.2008.01.014 · DOI
- Kawamata, 2008, Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray., Blood, 111, 776, 10.1182/blood-2007-05-088310 · DOI · Paper page
- Mirebeau, 2006, The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood: results of the EORTC studies 58881 and 58951., Haematologica, 91, 881
- Russell, 2008, t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)., Blood, 111, 387, 10.1182/blood-2007-07-092015 · doi:10.1182/blood-2007-07-092015
- Teh, 2005, Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event., Cancer Res, 65, 8597, 10.1158/0008-5472.CAN-05-0842 · DOI · Paper page
- Hu, 2005, Genome-wide association study in esophageal cancer using GeneChip mapping 10K array., Cancer Res, 65, 2542, 10.1158/0008-5472.CAN-04-3247 · DOI
- Raghavan, 2005, Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias., Cancer Res, 65, 375, 10.1158/0008-5472.375.65.2 · DOI · Paper page
- Fitzgibbon, 2005, Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias., Cancer Res, 65, 9152, 10.1158/0008-5472.CAN-05-2017 · DOI · Paper page
- Moorman, 2003, Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia., Blood, 102, 2756, 10.1182/blood-2003-04-1128 · DOI · Paper page
- Carter, 2001, Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse., Blood, 97, 572, 10.1182/blood.V97.2.572 · DOI
- Ramakers-van Woerden, 2001, In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia., Br J Haematol, 112, 680, 10.1046/j.1365-2141.2001.02586.x · DOI
- Dalle, 2002, p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia., Blood, 99, 2620, 10.1182/blood.V99.7.2620 · doi:10.1182/blood.v99.7.2620
- Zhou, 1997, Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia., Pediatr Hematol Oncol, 14, 141, 10.3109/08880019709030900 · DOI
- Fizzotti, 1995, Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features., Blood, 85, 2685, 10.1182/blood.V85.10.2685.bloodjournal85102685 · DOI
- van Zutven, 2005, CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia., Leukemia, 19, 1281, 10.1038/sj.leu.2403769 · DOI
- Graf Einsiedel, 2002, Deletion analysis of p16INKa and p15INKb in relapsed childhood acute lymphoblastic leukemia., Blood, 99, 4629, 10.1182/blood.V99.12.4629 · DOI
- Heerema, 1999, Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group., Blood, 94, 1537
- Hann, 2001, Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol., Br J Haematol, 113, 103, 10.1046/j.1365-2141.2001.02668.x · doi:10.1046/j.1365-2141.2001.02668.x
Cited by
Russell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
Self-citationMarks, D. I., Paietta, E. M., Moorman, A. V., Richards, S. M., Buck, G., DeWald, G., Ferrando, A., Fielding, A. K., Goldstone, A. H., Ketterling, R. P., et al. (2009) · Blood · doi:10.1182/blood-2009-08-231217 · Cited by 420
Self-citationThe genomic landscape of pediatric acute lymphoblastic leukemia
Brady, S. W., Roberts, K. G., Gu, Z., Shi, L., Pounds, S., Pei, D., Cheng, C., Dai, Y., Devidas, M., Qu, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01159-z · Cited by 391
Moorman, A. V., Ensor, H. M., Richards, S. M., Chilton, L., Schwab, C., Kinsey, S. E., Vora, A., Mitchell, C. D., & Harrison, C. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70066-8 · Cited by 390
Self-citationFielding, A. K., Rowe, J. M., Richards, S. M., Buck, G., Moorman, A. V., Durrant, I. J., Marks, D. I., McMillan, A. K., Litzow, M. R., Lazarus, H. M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199380 · Cited by 291
Self-citation
Metadata
- Authors
- Sulong, S., Moorman, A. V., Irving, J. A. E., Strefford, J. C., Konn, Z. J., Case, M. C., Minto, L., Barber, K. E., Parker, H., Wright, S. L., Stewart, A. R. M., Bailey, S., Bown, N. P., Hall, A. G., & Harrison, C. J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-01-01
- Volume
- 113
- Issue
- 1
- Pages
- 100-107
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1973850616
- Cited by
- 207
- References
- 3
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. https://app.cochat.ai/papers/10.1182/blood-2008-07-166801
- The paper
- Sulong, S., Moorman, A. V., Irving, J. A. E., Strefford, J. C., Konn, Z. J., Case, M. C., Minto, L., Barber, K. E., Parker, H., Wright, S. L., Stewart, A. R. M., Bailey, S., Bown, N. P., Hall, A. G., & Harrison, C. J. (2009). A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood. https://doi.org/10.1182/blood-2008-07-166801
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.